Covered recipient · General Payments record
ADRIENNE TOUNSEL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2021
$1,639.63
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $190.90 | 11 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $65.98 | 3 |
| Lilly USA, LLC | $36.44 | 2 |
| GlaxoSmithKline, LLC. | $32.96 | 2 |
| Novo Nordisk AS | $19.78 | 1 |
| Janssen Pharmaceuticals, Inc | $13.22 | 1 |
| ABBVIE INC. | $11.37 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $11.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $11.37 | 01/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796165185 | CMS |
| Gilead Sciences, Inc. | $21.37 | 01/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848290031 | CMS |
| Gilead Sciences, Inc. | $24.95 | 04/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848290033 | CMS |
| Gilead Sciences, Inc. | $19.66 | 08/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848290035 | CMS |
| GlaxoSmithKline, LLC. | $16.06 | 02/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 801574243 | CMS |
| GlaxoSmithKline, LLC. | $16.90 | 08/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 802655365 | CMS |
| Janssen Pharmaceuticals, Inc | $13.22 | 06/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788801469 | CMS |
| Lilly USA, LLC | $20.93 | 01/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818904515 | CMS |
| Lilly USA, LLC | $15.51 | 06/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818911553 | CMS |
| Novo Nordisk Inc | $19.78 | 05/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811378005 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $11.15 | 04/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 820306693 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.